Azusa Dialysis Center, Llc is a medicare approved dialysis facility center in Azusa, California and it has 24 dialysis stations. It is located in Los Angeles county at 312 N. Azusa Avenue, Azusa, CA, 91702. You can reach out to the office of Azusa Dialysis Center, Llc at (626) 633-1500. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Azusa Dialysis Center, Llc has the following ownership type - Profit. It was first certified by medicare in March, 2007. The medicare id for this facility is 552573 and it accepts patients under medicare ESRD program.
| Name | Azusa Dialysis Center, Llc |
|---|---|
| Location | 312 N. Azusa Avenue, Azusa, California |
| No. of Dialysis Stations | 24 |
| Medicare ID | 552573 |
| Managed By | Independent |
| Ownership Type | Profit |
| Late Shifts | No |
| 312 N. Azusa Avenue, Azusa, California, 91702 | |
| (626) 633-1500 | |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
| NPI Number | 1578775045 |
| Doing Business As | Azusa Dialysis Center, Llc |
| Address | 312 N Azusa Ave Azusa, California, 91702 |
| Phone Number | (626) 633-1500 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 46 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 63 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 123 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 850 |
| Percentage of adult patients getting regular hemodialysis at the center | 88 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Azusa Dialysis Center, Llc with elevated calcium levels.
| Patients with hypercalcemia | 130 |
| Hypercalcemia patient months | 902 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 3 |
| Patients with Serumphosphor | 139 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 30 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 36 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 15 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 103 |
| Patient months included in arterial venous fistula and catheter summaries | 614 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 61 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 26 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 99 |
| Hospitalization Rate in facility | 280.1 (Worse than Expected) |
| Hospitalization Rate: Upper Confidence Limit | 416.5 |
| Hospitalization Rate: Lower Confidence Limit | 192.5 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at Azusa Dialysis Center, Llc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 28.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 37.4 |
| Readmission Rate: Lower Confidence Limit | 20.4 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Azusa Dialysis Center, Llc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 75 |
| Transfusion Rate in facility | 104.1 (Worse than Expected) |
| Transfusion Rate: Upper Confidence Limit | 175.3 |
| Transfusion Rate: Lower Confidence Limit | 65.9 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at Azusa Dialysis Center, Llc lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 500 |
| Mortality Rate in facility | 39.6 (Worse than Expected) |
| Mortality Rate: Upper Confidence Limit | 47.6 |
| Mortality Rate: Lower Confidence Limit | 32.6 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago
Azusa Dialysis Center, Llc Location: 312 N. Azusa Avenue, Azusa, California, 91702 Phone: (626) 633-1500 |
News Archive
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
Since China ended its one-child policy allowing all families to have up to two children, an additional 90 million women have become eligible to have a second child. But new UBC sociology research suggests the new universal two-child policy could be negatively affecting women's status and gender equality.
In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.
› Verified 4 days ago